Results 301 to 310 of about 124,541 (336)
Some of the next articles are maybe not open access.

Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors

Archiv der Pharmazie, 2021
To develop new acetylcholinesterase (AChE)–monoamine oxidase‐B (MAO‐B) dual inhibitors against Alzheimer's disease, the benzimidazole ring, which has a propargyl side chain with previously proven selective MAO‐B inhibitory activity, was used as the main ...
Derya Osmaniye   +5 more
semanticscholar   +1 more source

Identification and molecular docking study of fish roe-derived peptides as potent BACE 1, AChE, and BChE inhibitors.

Food & Function, 2020
Acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and beta-secretase 1 (BACE 1) play vital roles in the development and progression of Alzheimer's disease (AD). The objective of the present study was to identify fish roe-derived anti-AD peptides
Zhipeng Yu   +7 more
semanticscholar   +1 more source

Acetylcholinesterase Enzyme (AChE) as a Biosensor and Biomarker for Pesticides: A Mini Review

Bulletin of Environmental Science and Sustainable Management (e-ISSN 2716-5353), 2020
Due to the increase in pesticide usage the cost of food production has been drastically reduced worldwide. There are dangers related to the ever-increasing pesticide application especially to the non-target biota and to also to the environment at large ...
A. M. Umar, Abubakar Aisami
semanticscholar   +1 more source

Near-Infrared Fluorescence Probe for Evaluating Acetylcholinesterase (AChE) Activity in PC12 Cells and In Situ Tracing AChE Distribution in Zebrafish.

ACS Sensors, 2019
Acetylcholinesterase (AChE) plays crucial roles in numerous physiological processes such as cell differentiation, cell apoptosis, and nerve tissues development.
Jianlong Ma   +6 more
semanticscholar   +1 more source

Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer's Disease.

ACS Chemical Neuroscience, 2018
A series of dual-target AChE/PDE9A inhibitor compounds were designed, synthesized, and evaluated as anti-Alzheimer's Disease (AD) agents. Among these target compounds, 11a (AChE: IC50 = 0.048 μM; PDE9A: IC50 = 0.530 μM) and 11b (AChE: IC50 = 0.223 μM ...
Jinhui Hu   +7 more
semanticscholar   +1 more source

Acetylcholinesterase (AChE) Activity in Embryos of Zebrafish.

Methods in molecular biology, 2021
C. Gravato   +4 more
semanticscholar   +1 more source

Molecular docking and investigation of 4-(benzylideneamino)- and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors

Chemické zvesti, 2019
M. Işık   +5 more
semanticscholar   +1 more source

Neuroprotective effects of matrine on scopolamine-induced amnesia via inhibition of AChE/BuChE and oxidative stress

Metabolic brain disease, 2018
Kaiyue Sun   +6 more
semanticscholar   +1 more source

Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease.

ACS Chemical Neuroscience, 2017
Fei Mao   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy